Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 6-Month Open Label, Flexible-Dosage Study to Assess the Safety and Effectiveness of PROVIGIL (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome

NCT00214968 is registered in ClinicalTrials.gov with Cephalon as lead sponsor.

NCT NCT00214968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00214968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 6-Month Open Label, Flexible-Dosage Study to Assess the Safety and Effectiveness of PROVIGIL (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome
Lead sponsor
Cephalon
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2005
Completion date
October 31, 2005
Enrollment
92 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

narcolepsy